Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
Ming Cheng(University of Arizona), Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center), Morgan Huse(Memorial Sloan Kettering Cancer Center), Brian H. Santich(Memorial Sloan Kettering Cancer Center), Hong Xu(Jilin University), Mahiuddin Ahmed(Memorial Sloan Kettering Cancer Center)
Cited by 41
Related Papers
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k